Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy in adults and accounts for 85–90% of all primary liver cancer. Based on the estimation by the International Agency for Research on Cancer in 2018, liver cancer is the fourth leading cause of cancer death globally. Dihydroarte...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tzu-En, Deng, Yi-Ning, Hsu, Jui-Ling, Leu, Wohn-Jenn, Marchesi, Elena, Capobianco, Massimo L., Marchetti, Paolo, Navacchia, Maria Luisa, Guh, Jih-Hwa, Perrone, Daniela, Hsu, Lih-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748086/
https://www.ncbi.nlm.nih.gov/pubmed/33343369
http://dx.doi.org/10.3389/fphar.2020.599067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748086/
https://www.ncbi.nlm.nih.gov/pubmed/33343369
http://dx.doi.org/10.3389/fphar.2020.599067

Ejemplares similares